17β-methyl-4-androsten-3-one | 39006-59-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 17β-methyl-4-androsten-3-one
• 英文别名: 17β-methyl-androst-4-en-3-one；(8S,9S,10R,13R,14S)-10,13,17-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one；17β-Methyl-androst-4-en-3-on；17beta-Methylandrost-4-en-3-one；(8S,9S,10R,13R,14S,17S)-10,13,17-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
• CAS: 39006-59-2
• 化学式: C₂₀H₃₀O
• 分子量: 286.458
• InChiKey: SFQNDRJWBXMSPE-ZFRJDGDFSA-N

物化性质

• 熔点：
  109.5-110.5 °C
• 沸点：
  398.4±9.0 °C(Predicted)
• 密度：
  1.03±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  21
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.85
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  17β-methyl-4-androsten-3-one 、 sodium sulfate 在 lithium aluminium tetrahydride 作用下， 生成 17β-Methylandrost-4-en-3-ol
  参考文献：
  名称：

  Steroids as neurochemical stimulators of the VNO to alleviate symptoms

  摘要：

  该发明涉及一种缓解经前期综合征和焦虑症状的方法。该方法包括通过鼻腔给药一种类固醇物质，即一种人类呕吐素，使得呕吐素与特定的神经上皮受体结合。所述类固醇物质通常以含有一种或多种药用载体的药物组合物的形式给予。

  公开号：

  US06057439A1
• 作为产物：
  描述：

  17-甲睾酮 在 偶氮二异丁腈 、 三正丁基氢锡 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 苯 为溶剂， 反应 2.58h， 生成 17β-methyl-4-androsten-3-one
  参考文献：
  名称：

  Radical Deoxygenation of Hydroxyl Groups via Phosphites

  摘要：

  A highly efficient, two-step sequence method for the deoxygenation of hydroxyl groups has been developed. The method involves the preparation of the 2-(2-iodophenyl)ethyl methyl phosphite derivative of an alcohol using methyl dichlorophosphite and 2-(2-iodophenyl)ethanol. Treatment of the phosphite intermediate with (n-Bu)3SnH/AIBN in refluxing benzene cleanly produces the deoxygenation product of the original alcohol.

  DOI：

  10.1021/ja0462777

文献信息

• Zn-Mediated Hydrodeoxygenation of Tertiary Alkyl Oxalates
  作者：Hegui Gong、Yang Ye、Guobin Ma、Ken Yao

  DOI：10.1055/a-1328-0352

  日期：2021.10

  Herein we describe a general, mild, and scalable method for hydrodeoxygenation of readily accessible tertiary alkyl oxalates by Zn/silane under Ni-catalyzed conditions. The reduction method is suitable for an array of structural motifs derived from tertiary alcohols that bear diverse functional groups, including the synthesis of a key intermediate en route to estrone.

  本文中，我们描述了在Ni催化条件下通过Zn /硅烷对易获得的叔烷基草酸酯进行加氢脱氧的一般，温和和可扩展的方法。还原方法适用于衍生自带有不同官能团的叔醇的一系列结构基序，包括在通往雌酮的途中合成关键中间体。
• Steroids as neurochemical initiators of change in human blood levels of
  申请人：Pherin Corporation

  公开号：US06066627A1

  公开（公告）日：2000-05-23

  The invention relates to a method of altering the blood levels of LH or FSH in an individual. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

  该发明涉及一种改变个体血液中LH或FSH水平的方法。该方法包括经鼻给药一种类固醇物质，该类固醇物质是一种人类嗅觉素，使得该嗅觉素结合到特定的神经上皮受体上。该类固醇或多种类固醇最好以含有一个或多个药用载体的制药组合物的形式给药。
• Steroids as neurochemical stimulators of the VNO to treat paroxistic
  申请人：Pherin Pharmaceuticals, Inc.

  公开号：US06117860A1

  公开（公告）日：2000-09-12

  The invention relates to a method of alleviating the symptoms of PMS and anxiety. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

  该发明涉及一种缓解经前期综合症和焦虑症状的方法。该方法包括经鼻给药一种类固醇物质，即人类呕吐素，使得呕吐素与特定的神经上皮受体结合。该类固醇物质或多种类固醇物质最好以含有一种或多种药用载体的药物组合物的形式给予。
• Steroids as neurochemical stimulators of the VNO to alleviate pain
  申请人：Pherin Pharmaceuticals, Inc.

  公开号：US06331534B1

  公开（公告）日：2001-12-18

  The invention relates to a method of alleviating pain. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

  该发明涉及一种缓解疼痛的方法。该方法包括经鼻给药一种类固醇，该类固醇为一种人类呕吐素，使得呕吐素与特定的神经上皮受体结合。该类固醇或多种类固醇最好以含有一种或多种药用载体的制药组合物的形式给予。
• Steroids and sex hormones. Part 262. The radical induced stannane reduction of selenoesters and selenocarbonates: A new method for the degradation of carboxylic acids to nor-alkanes and for desoxygenation of alcohols to alkanes
  作者：Johannes Pfenninger、Christoph Heuberger、Walter Graf

  DOI：10.1002/hlca.19800630823

  日期：1980.12.10

  Esters of carboselenoic acids, formed from carboxylic acids by conventional methods, undergo reaction with tributyltin hydride in inert aromatic solvents, either by heating to give the corresponding aldehyde or the corresponding alkane depending on reaction temperature and the structure of the parent carboxylic acid, or by ultraviolet irradiation at ambient temperature when the aldehyde is formed predominantly

  通过常规方法，由羧酸形成的碳硒烯酸酯与三丁基锡氢化物在惰性芳族溶剂中反应，取决于反应温度和母体羧酸的结构，通过加热生成相应的醛或相应的烷烃，或通过当主要以高产率形成醛时，在环境温度下进行紫外线照射。在α，β-不饱和碳硒烯酸酯的情况下，热反应仅导致相应的醛。